7-Methoxy-1-[(E)-2-(4-nitro-phenyl)-vinyl]-9H-beta-carboline

ID: ALA112452

Cas Number: 17019-08-8

PubChem CID: 6250668

Max Phase: Preclinical

Molecular Formula: C20H15N3O3

Molecular Weight: 345.36

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Synonyms: TCMDC-125486 | TCMDC-125486 | TCMDC-125486|17019-08-8|NSC371712|CHEMBL112452|SCHEMBL12305583|DTXSID30422251|NSC-371712|7-methoxy-1-[(E)-2-(4-nitrophenyl)vinyl]-9H-pyrido[3,4-b]indole|9H-pyrido[3,4-b]indole, 7-methoxy-1-[(E)-2-(4-nitrophenyl)ethenyl]-

Canonical SMILES:  COc1ccc2c(c1)[nH]c1c(/C=C/c3ccc([N+](=O)[O-])cc3)nccc12

Standard InChI:  InChI=1S/C20H15N3O3/c1-26-15-7-8-16-17-10-11-21-18(20(17)22-19(16)12-15)9-4-13-2-5-14(6-3-13)23(24)25/h2-12,22H,1H3/b9-4+

Standard InChI Key:  RACKRQSOLIUNNO-RUDMXATFSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    3.6402   -8.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6391   -9.6648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3539  -10.0777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3521   -8.4247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0675   -8.8338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0723   -9.6603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8598   -9.9111    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8520   -8.5739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3373   -9.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1531   -9.1490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4846   -8.3965    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9942   -7.7322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1802   -7.8246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6406   -9.8145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9243  -10.0768    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2101   -9.6637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3080  -10.5695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7956  -11.2350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4609  -11.9884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9477  -12.6535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7688  -12.5644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1007  -11.8045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6118  -11.1425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2606  -13.2291    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0806  -13.1385    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9290  -13.9845    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
 12 13  2  0
 13  8  1  0
  3  6  2  0
 10 14  1  0
  6  7  1  0
  2 15  1  0
  7  9  1  0
 15 16  1  0
  8  5  1  0
 14 17  2  0
  1  2  2  0
 17 18  1  0
  5  4  2  0
 18 19  2  0
  8  9  2  0
 19 20  1  0
  4  1  1  0
 20 21  2  0
  9 10  1  0
 21 22  1  0
  5  6  1  0
 22 23  2  0
 23 18  1  0
 10 11  2  0
 11 12  1  0
 24 25  2  0
 24 26  1  0
 21 24  1  0
M  CHG  2  24   1  26  -1
M  END

Associated Targets(Human)

KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAKI-1 (44928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
1A9 (618 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SAOS-2 (672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-2 (46422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-87 MG (3946 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
H9 (1832 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC2A1 Tchem Glucose transporter (14755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LmGT2 Glucose transporter (14035 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ht1 Hexose transporter 1 (14071 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 345.36Molecular Weight (Monoisotopic): 345.1113AlogP: 4.80#Rotatable Bonds: 4
Polar Surface Area: 81.05Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.06CX Basic pKa: 5.07CX LogP: 4.23CX LogD: 4.23
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.43Np Likeness Score: -0.15

References

1. Ishida J, Wang HK, Bastow KF, Hu CQ, Lee KH..  (1999)  Antitumor agents 201. Cytotoxicity of harmine and beta-carboline analogs.,  (23): [PMID:10612592] [10.1016/s0960-894x(99)00598-3]
2. Ishida J, Wang HK, Oyama M, Cosentino ML, Hu CQ, Lee KH..  (2001)  Anti-AIDS agents. 46. Anti-HIV activity of harman, an anti-HIV principle from Symplocos setchuensis, and its derivatives.,  64  (7): [PMID:11473435] [10.1021/np0101189]
3. Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DV, Kumar V, Hasan S, Brown JR, Peishoff CE, Cardon LR, Garcia-Bustos JF..  (2010)  Thousands of chemical starting points for antimalarial lead identification.,  465  (7296): [PMID:20485427] [10.1038/nature09107]
4. St. Jude Leishmania screening dataset.,  [10.6019/CHEMBL3433997]
5. Luo B, Song X..  (2021)  A comprehensive overview of β-carbolines and its derivatives as anticancer agents.,  224  [PMID:34332400] [10.1016/j.ejmech.2021.113688]